True Wealth Design’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.08K Hold
564
– – ﹤0.01% 1420
2026
Q2
$5.64K Sell
564
-18
-3% -$136 ﹤0.01% 1284
2026
Q1
$4.19K Hold
582
– – ﹤0.01% 1265
2025
Q4
$3.28K Buy
582
+18
+3% +$98 ﹤0.01% 1257
2025
Q3
$3.48K Hold
564
– – ﹤0.01% 1232
2025
Q2
$2.75K Buy
564
+246
+77% +$870 ﹤0.01% 1040
2025
Q1
$1.18K Buy
+318
New +$1.36K ﹤0.01% 1209

Other funds holding SLDB

True Wealth Design's SLDB Position: Q3 2026 in Review

True Wealth Design held its Solid Biosciences (SLDB) position steady in Q3 2026 at 564 shares worth $4.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

True Wealth Design first reported a position in SLDB in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.64K in Q2 2026. 9 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

  • True Wealth Design held 564 shares of Solid Biosciences worth $4.08K as of Q3 2026.
  • True Wealth Design left its Solid Biosciences share count unchanged in Q3 2026.
  • Solid Biosciences made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1420 holding.
  • True Wealth Design first reported a position in Solid Biosciences in Q1 2025 and has held it in 7 quarters since.
  • True Wealth Design's Solid Biosciences position peaked at $5.64K in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.